PNC Financial Services Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
JSAM
AT
AWC
PNC Financial Services Group's PPH Position: Q2 2026 in Review
PNC Financial Services Group held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 963 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2890.
PNC Financial Services Group first reported a position in PPH in Q2 2013 and has held it in 22 quarters since. The position peaked at $167K in Q1 2015. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- PNC Financial Services Group held 963 shares of VanEck Pharmaceutical ETF worth $105K as of Q2 2026.
- PNC Financial Services Group left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
- VanEck Pharmaceutical ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2890 holding.
- PNC Financial Services Group first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 22 quarters since.
- PNC Financial Services Group's VanEck Pharmaceutical ETF position peaked at $167K in Q1 2015.
- 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.